Abstract
Objective: We evaluated the association between organochlorines and breast cancer subtype defined by the tumor characteristics: estrogen receptor status, progesterone receptor status, tumor size, and grade.
Methods: A case–control study was conducted from 1995 to 1997 in Kingston and Toronto, Canada. Breast adipose tissue, taken from 217 cases and 213 biopsy controls frequency-matched on age, was analysed for 14 polychlorinated biphenyl (PCB) congeners and 10 pesticides.
Results: Adjusting for age, geometric means of several organochlorines differed by estrogen receptor status and tumor grade (p < 0.05). Odds ratios (ORs) for each organochlorine relative to the common control group for breast cancers of differing subtype were compared using polytomous logistic regression. Although the ORs did not differ significantly by subtype, the ORs of PCBs and p, p′-1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) were higher with risk of estrogen receptor-negative breast cancer than estrogen receptor-positive breast cancer. One of the most extreme differences was with DDE, where the OR for the association with risk of estrogen receptor-negative breast cancer was 2.4 (95% confidence interval (CI) 1.0–5.4) in the uppermost tertile relative to the lowest, whereas the corresponding OR for risk of estrogen receptor-positive breast cancer was 1.1 (95% CI 0.6–1.9). PCBs also tended to be more strongly positively associated with risk of larger and higher-grade tumors.
Conclusions: The association between organochlorines and breast cancer risk did not significantly differ by subtype, but many PCBs were more strongly associated with tumors of poor prognosis.
Similar content being viewed by others
References
Wassermann M, Nogueira DP, Tomatis L, et al. (1976) Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol 15: 478–484.
Mussalo-Rauhamaa H, Hasanen E, Pyysalo H, Antervo K, Kauppila R, Pantzar P (1990) Occurrence of beta-hexachlorocyclohexane in breast cancer patients. Cancer 66: 2124-2128.
Falck FJ, Ricci AJ, Wolff MS, Godbold J, Deckers P (1992) Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47: 143–146.
Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N (1993) Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85: 648–652.
Güttes S, Failing K, Neumann K, Kleinstein J, Georgii S, Brunn H (1998) Chlororganic pesticides and polychlorinated biphenyls in breast tissue of women with benign and malignant breast disease. Arch Environ Contam Toxicol 35: 140–147.
Liljegren G, Hardell L, Lindström G, Dahl P, Magnuson A (1998) Case-control study on breast cancer and adipose tissue concentrations of congener specific polychlorinated biphenyls, DDE and hexachlorobenzene. Eur J Cancer Prev 7: 135–140.
Høyer AP, Grandjean P, Jørgensen T, Brock JW, Hartvig HB (1998) Organochlorine exposure and risk of breast cancer. Lancet 352: 1816–1820.
Unger M, Kiaer H, Blichert-Toft M, Olsen J, Clausen J (1984) Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environ Res 34: 24–28.
Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N (1994) Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst 86: 589–599.
Hunter DJ, Hankinson SE, Laden F, et al. (1997) Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 337: 1253–1258.
López-Carrillo L, Blair A, López-Cervantes M, et al. (1997) Dichlorodiphenyltrichloroethane serum levels and breast cancer risk: a case-control study from Mexico. Cancer Res 57: 3728–3732.
Schecter A, Toniolo P, Dai LC, Thuy LT, Wolff MS (1997) Blood levels of DDT and breast cancer risk among women living in the north of Vietnam. Arch Environ Contam Toxicol 33: 453–456.
van't Veer P, Lobbezoo IE, Martin-Moreno JM, et al. (1997) DDT (dicophane) and postmenopausal breast cancer in Europe: case-control study. BMJ 315: 81–85.
Olaya-Contreras P, Rodríguez-Villamil J, Posso-Valencia HJ, Cortez JE (1998) Organochlorine exposure and breast cancer risk in Colombian women. Cad Saude Publica, Rio de Janeiro 14: 125–132.
Dorgan JF, Brock JW, Rothman N, et al. (1999) Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA) Cancer Causes Control 10: 1–11.
Wolff MS, Zeleniuch-Jacquotte A, Dubin N, Toniolo P (2000) Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 9: 271–277.
Stanford JL, Szklo M, Brinton LA (1986) Estrogen receptors and breast cancer. Epidemiol Rev 8: 42–59.
Habel LA, Stanford JL (1993) Hormone receptors and breast cancer. Epidemiol Rev 15: 209–219.
Potter JD, Cerhan JR, Sellers TA, et al. (1995) Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 4: 319–326.
Yoo K-Y, Tajima K, Miura S, et al. (1997) Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am J Epidemiol 146: 307–314.
Dewailly É, Dodin S, Verreault R, et al. (1994) High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst 86: 232–234.
Aronson KJ, Miller AB, Woolcott CG, et al. (2000) Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev 9: 55–63.
Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly É (2000) Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev 9: 161–166.
Zheng T, Holford TR, Mayne ST, et al. (2000) Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev 9: 167–174.
Zheng T, Holford TR, Mayne ST, et al. (1999) Beta-benzene hexachloride in breast adipose tissue and risk of breast carcinoma. Cancer 85: 2212–2218.
Zheng T, Holford TR, Mayne ST, et al. (1999) Environmental exposure to hexachlorobenzene (HCB) and risk of female breast cancer in Connecticut. Cancer Epidemiol Biomarkers Prev 8: 407–411.
Helzlsouer KJ, Alberg AJ, Huang H-Y, et al. (1999) Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev 8: 525–532.
Zhu K, Bernard LJ, Levine RJ, Williams SM (1997) Estrogen receptor status of breast cancer: a marker of different stages of tumor or different entities of the disease? Med Hypotheses 49: 69–75.
Wolff MS, Camann D, Gammon M, Stellman SD (1997) Proposed PCB congener groupings for epidemiological studies. Environ Health Perspect 105: 13–14.
Høyer AP, Jørgensen T, Brock JW, Grandjean P (2000) Organochlorine exposure and breast cancer survival. J Clin Epidemiol 53: 323–330.
Pearce N, de Sanjose S, Boffetta P, Kogevinas M, Saracci R, Savitz D (1995) Limitations of biomarkers of exposure in cancer epidemiology. Epidemiology 6: 190–194.
Kohlmeier L, Kohlmeier M (1995) Adipose tissue as a medium for epidemiologic exposure assessment. Environ Health Perspect 103(Suppl. 3): 99–106.
Enger SM, Ross RK, Paganini-Hill A, Longnecker MP, Bernstein L (1999) Alcohol consumption and breast cancer oestrogen and progesterone receptor status. Br J Cancer 79: 1308–1314.
Huang W-H, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151: 703–714.
Khan SA, Rogers MA, Khurana KK, Meguid MM, Numann PJ (1998) Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst 90: 37–42.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woolcott, C.G., Aronson, K.J., Hanna, W.M. et al. Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control 12, 395–404 (2001). https://doi.org/10.1023/A:1011289905751
Issue Date:
DOI: https://doi.org/10.1023/A:1011289905751